BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ouvrard E, Chevalier E, Addeo P, Sahakian N, Detour J, Goichot B, Bachellier P, Karcher G, Taïeb D, Imperiale A. Intraindividual comparison of 18 F-FDOPA and 68 Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours. Clin Endocrinol (Oxf) 2021;94:66-73. [PMID: 32790887 DOI: 10.1111/cen.14312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Imperiale A, Meuter L, Pacak K, Taïeb D. Imaging of Small Intestine Neuroendocrine Neoplasms: Is SSTR PET the Holy Grail? J Nucl Med 2021;62:1347-8. [PMID: 33771907 DOI: 10.2967/jnumed.121.262140] [Reference Citation Analysis]
2 Imperiale A, Meuter L, Pacak K, Taïeb D. Variants and Pitfalls of PET/CT in Neuroendocrine Tumors. Semin Nucl Med 2021;51:519-28. [PMID: 33838874 DOI: 10.1053/j.semnuclmed.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cazzato RL, Hubelé F, De Marini P, Ouvrard E, Salvadori J, Addeo P, Garnon J, Kurtz JE, Greget M, Mertz L, Goichot B, Gangi A, Imperiale A. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers (Basel) 2021;13:6368. [PMID: 34944988 DOI: 10.3390/cancers13246368] [Reference Citation Analysis]
4 Piccardo A, Fiz F, Bottoni G, Ugolini M, Noordzij W, Trimboli P. Head-to-head comparison between 18 F-DOPA PET/CT and 68 Ga-DOTA-peptide PET/CT in detecting intestinal neuroendocrine tumours: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 2021. [PMID: 34018606 DOI: 10.1111/cen.14527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdom Radiol. [DOI: 10.1007/s00261-022-03516-2] [Reference Citation Analysis]